WallStSmart

Zepp Health Corp (ZEPP)vszSpace, Inc. Common stock (ZSPC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 829% more annual revenue ($258.90M vs $27.86M). ZEPP leads profitability with a -15.5% profit margin vs -91.1%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0

ZSPC

Avoid

22

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Intrinsic value data unavailable for ZSPC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

ZSPC0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

ZSPC4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.34M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Revenue GrowthGrowth
-43.2%2/10

Revenue declined 43.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bull Case : ZSPC

ZSPC has a balanced fundamental profile.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Bear Case : ZSPC

The primary concerns for ZSPC are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

ZEPP profiles as a hypergrowth stock while ZSPC is a turnaround play — different risk/reward profiles.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor CONSUMER ELECTRONICS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 22/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

zSpace, Inc. Common stock

TECHNOLOGY · COMPUTER HARDWARE · USA

zSpace, Inc. (ZSPC) is a pioneering technology firm at the forefront of augmented reality (AR) and virtual reality (VR) innovations, primarily aimed at revolutionizing educational and professional training environments. By developing cutting-edge hardware and proprietary software, zSpace delivers immersive simulations that facilitate deeper comprehension of complex subjects in science, engineering, and design. As a key player in the rapidly expanding AR/VR sector, zSpace is dedicated to enhancing educational outcomes and cultivating essential skills, positioning itself as an attractive investment prospect for institutional investors seeking to leverage the evolution of educational technology.

Want to dig deeper into these stocks?